Table 7. Influence of the physicians’ clinical suspicion of tuberculosis (CSTB) on rate of QFT-GIT results in active pulmonary TB patients according to their disease localisation and HIV status.

HIV status	TB diagnosis*	CSTB Low	CSTB High	CSTB Very High	p value “TB Diagnosis” vs “CSTB very high
	N of QFT-GIT-responders/N of patients tested (%)
HIV-infected	26/38 (68.4)	0/0 (NA)	13/19 (68.4)	13/19 (68.4)	1.000
HIV-uninfected	53/58 (91.4)	0/0 (NA)	5/7 (71.4 )	48/51 (94.1)	0.7209
Total	79/96(82.3)	0/0 (NA)	18/26 (69.2)	62/76 (81.6)	1.000

Footnotes: QFT-GIT: QuantiFERON® Gold in Tube; TB: tuberculosis;

^*TB diagnosis by QFT-GIT (“clinical sensitivity”) within the group considered; HIV: human immunodeficiency virus; CSTB: clinical suspicion of TB; NA: not applicable.